Healthcare
Sunday, December 18, 2016
BRIEF-Shionogi & Co Ltd signs strategic business alliance for sale of peripheral mu opioid receptor antagonist Symproic in U.S with Purdue Pharma L.P
* Says it signed a strategic business alliance for sale of
peripheral mu opioid receptor antagonist Symproic in U.S with
Purdue Pharma L.P
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment